CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 55 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $509,000 | +97.3% | 104,527 | 0.0% | 0.00% | – |
| Q1 2021 | $258,000 | +4200.0% | 104,527 | +1380.8% | 0.00% | – |
| Q2 2019 | $6,000 | -91.4% | 7,059 | -86.4% | 0.00% | – |
| Q1 2019 | $70,000 | -87.8% | 52,021 | -90.3% | 0.00% | – |
| Q4 2018 | $573,000 | -50.9% | 536,761 | +182.2% | 0.00% | – |
| Q3 2018 | $1,168,000 | +7.8% | 190,195 | +87.4% | 0.00% | – |
| Q2 2018 | $1,083,000 | +259.8% | 101,484 | +260.3% | 0.00% | – |
| Q1 2018 | $301,000 | -9.1% | 28,168 | -40.7% | 0.00% | – |
| Q4 2017 | $331,000 | +7.1% | 47,523 | +33.8% | 0.00% | – |
| Q3 2017 | $309,000 | -71.5% | 35,511 | -70.3% | 0.00% | -100.0% |
| Q2 2017 | $1,086,000 | +159.2% | 119,431 | +125.2% | 0.00% | – |
| Q1 2017 | $419,000 | +212.7% | 53,027 | +247.6% | 0.00% | – |
| Q4 2016 | $134,000 | -22.5% | 15,257 | +52.6% | 0.00% | – |
| Q3 2016 | $173,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 169,629 | $147,560 | 0.05% |
| BROWN WEALTH MANAGEMENT, LLC | 110,000 | $95,689 | 0.05% |
| Carmignac Gestion | 2,132,744 | $1,855,274 | 0.03% |
| WATER ISLAND CAPITAL LLC | 82,500 | $72 | 0.01% |
| Northeast Financial Consultants Inc | 83,000 | $72,202 | 0.01% |
| XTX Topco Ltd | 27,545 | $23,961 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,600 | $152,754 | 0.00% |
| Curi Wealth Management, LLC | 25,000 | $21,748 | 0.00% |
| Banque Cantonale Vaudoise | 40,000 | $35 | 0.00% |
| SYNOVUS FINANCIAL CORP | 58,071 | $50,516 | 0.00% |